Journal of the American Society of Nephrology, Vol 3, 1753-1764, Copyright © 1993 by American Society of Nephrology

REGULAR ARTICLES

Dysfunction of glomerular fibrinolysis in experimental antiglomerular basement membrane antibody glomerulonephritis

L Feng, WW Tang, DJ Loskutoff and CB Wilson
Department of Immunology, Scripps Research Institute, La Jolla, CA.

Glomerular plasminogen activator inhibitor-1 (PAI-1) steady-state mRNA and bioactivity were increased after the induction of an augmented form of antiglomerular basement membrane (GBM) antibody glomerulonephritis. PAI-1 mRNA expression was noted at 6 h, peaking at 1 day, and although falling thereafter, remained higher than that of the control group through Day 17. PAI-1 mRNA expression correlated with glomerular PAI-1 bioactivity as determined by a functional tissue type plasminogen activator (t-PA) binding assay. Glomerular PAI-1 bioactivity, not detected in controls, increased to 1.4 +/- 0.3 ng/mg of glomerular lysate at 6 h and then decreased to 0.7 +/- 0.1 ng/mg of glomerular lysate by Day 6. The mRNA of the plasminogen activators (urokinase plasminogen activator), t-PA) either remained unchanged or declined through Day 1, with a slight increase in t-PA mRNA at Day 6. Interleukin-1 beta mRNA expression was maximal at 6 h, declining by Day 3. Transforming growth factor beta 1 (TGF-beta 1) mRNA began to increase at Day 1, was maximal at Day 6, and fell only slightly by Day 17. Epidermal growth factor mRNA decreased. The increase in PAI-1 mRNA and bioactivity, possibly induced early by the interleukin-1 beta response and perhaps later by the TGF-beta 1 response, was associated with striking glomerular capillary lumen fibrin accumulations on Day 1, which decreased and appeared to recanalize as the PAI-1 mRNA and bioactivity fell. The glomerular lesion continued to have some fibrin deposits even on Day 17 and, in addition, had changes of thickened GBM, suggestive of the early stages of diffuse glomerulosclerosis. The latter had a temporal relationship with the persisting increase in TGF- beta 1 and PAI-1 mRNA levels. These observations suggest the possibility that inhibition of enzymes capable of remodeling excessive extracellular matrix production may have contributed to the thickened GBM.

This article has been cited by other articles:

				H. Kimura, X. Li, K. Torii, T. Okada, N. Takahashi, H. Fujii, S. Ishihara, and H. Yoshida A natural PPAR-{gamma} agonist, 15-deoxy-delta 12,14-prostaglandin J2, may act as an enhancer of PAI-1 in human proximal renal tubular cells under hypoxic and inflammatory conditions Nephrol. Dial. Transplant., August 1, 2008; 23(8): 2496 - 2503. [Abstract] [Full Text] [PDF]

				S. Taneda, K. L. Hudkins, A. S. Muhlfeld, J. Kowalewska, J. W. Pippin, S. J. Shankland, and C. E. Alpers Protease Nexin-1, tPA, and PAI-1 are Upregulated in Cryoglobulinemic Membranoproliferative Glomerulonephritis J. Am. Soc. Nephrol., February 1, 2008; 19(2): 243 - 251. [Full Text] [PDF]

				A. Hertig and E. Rondeau Role of the Coagulation/Fibrinolysis System in Fibrin-Associated Glomerular Injury J. Am. Soc. Nephrol., April 1, 2004; 15(4): 844 - 853. [Abstract] [Full Text] [PDF]

				W. H. Baricos, J. C. Reed, and S. L. Cortez Extracellular Matrix Degradation by Cultured Mesangial Cells: Mediators and Modulators Experimental Biology and Medicine, October 1, 2003; 228(9): 1018 - 1022. [Abstract] [Full Text] [PDF]

				A. R. Kitching, Y. Z. Kong, X. Ru Huang, P. Davenport, K. L. Edgtton, P. Carmeliet, S. R. Holdsworth, and P. G. Tipping Plasminogen Activator Inhibitor-1 Is a Significant Determinant of Renal Injury in Experimental Crescentic Glomerulonephritis J. Am. Soc. Nephrol., June 1, 2003; 14(6): 1487 - 1495. [Abstract] [Full Text] [PDF]

				H. Kawano, S. Kim, K. Ohta, T. Nakao, H. Miyazaki, T. Nakatani, and H. Iwao Differential Contribution of Three Mitogen-Activated Protein Kinases to PDGF-BB-Induced Mesangial Cell Proliferation and Gene Expression J. Am. Soc. Nephrol., March 1, 2003; 14(3): 584 - 592. [Abstract] [Full Text] [PDF]

				A. A. Eddy Plasminogen activator inhibitor-1 and the kidney Am J Physiol Renal Physiol, August 1, 2002; 283(2): F209 - F220. [Abstract] [Full Text] [PDF]

				D. KONDO, T. YAMAMOTO, E. YAOITA, P. E. DANIELSON, H. KOBAYASHI, K. OHSHIRO, H. FUNAKI, Y. KOYAMA, H. FUJINAKA, K. KAWASAKI, et al. Localization of Olfactomedin-Related Glycoprotein Isoform (BMZ) in the Golgi Apparatus of Glomerular Podocytes in Rat Kidneys J. Am. Soc. Nephrol., May 1, 2000; 11(5): 803 - 813. [Abstract] [Full Text]

				W. H. BARICOS, S. L. CORTEZ, M. DEBOISBLANC, and S. XIN Transforming Growth Factor-{beta} Is a Potent Inhibitor of Extracellular Matrix Degradation by Cultured Human Mesangial Cells J. Am. Soc. Nephrol., April 1, 1999; 10(4): 790 - 795. [Abstract] [Full Text]

				H. Funaki, T. Yamamoto, Y. Koyama, D. Kondo, E. Yaoita, K. Kawasaki, H. Kobayashi, S. Sawaguchi, H. Abe, and I. Kihara Localization and expression of AQP5 in cornea, serous salivary glands, and pulmonary epithelial cells Am J Physiol Cell Physiol, October 1, 1998; 275(4): C1151 - C1157. [Abstract] [Full Text] [PDF]

				W. A. Border and N. A. Noble Interactions of Transforming Growth Factor-{beta} and Angiotensin II in Renal Fibrosis Hypertension, January 1, 1998; 31(1): 181 - 188. [Abstract] [Full Text] [PDF]

				Y. Jiang, H. Gram, M. Zhao, L. New, J. Gu, L. Feng, F. Di Padova, R. J. Ulevitch, and J. Han Characterization of the Structure and Function of the Fourth Member of p38 Group Mitogen-activated Protein Kinases, p38delta J. Biol. Chem., November 28, 1997; 272(48): 30122 - 30128. [Abstract] [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673